Questions? Call us at 800-810-7790
ZITUVIO for Type 2 Diabetes

Get generic ZITUVIO (sitagliptin) tablets for $80 per month

  • Available in 25, 50, and 100 mg tablets
  • Requires a valid prescription
  • No insurance needed

DPP-4 inhibitors have become increasingly popular as an additional treatment option for Type 2 Diabetes. These medications leverage the body's natural ability to regulate blood sugar, providing an effective and safe way to manage blood sugar levels.

However, they are usually quite expensive, with retail costs exceeding $600 per month, making them inaccessible for many who could benefit from them.

The good news is that the generic version of ZITUVIO (sitagliptin) is now available at Marley Drug for just $80 per month.

How can we offer generic sitagliptin when its not available at other pharmacies?

In 2023, the FDA approved ZITUVIO (sitagliptin). The manufacturers have authorized a generic for ZITUVIO, generic sitagliptin, which is sold exclusively through Marley Drug pharmacy at a cash price of $80/month. By buying direct from Marley Drug, patients can save on sitagliptin.

About ZITUVIO (sitagliptin)

ZITUVIO is approved for adults with Type 2 Diabetes to improve blood sugar control when used alongside diet and exercise. It is not suitable for individuals with Type 1 Diabetes or those with a history of pancreatitis.

In clinical studies, ZITUVIO (sitagliptin) has been shown to help lower A1C levels by 0.7% in individuals also taking metformin. This medication:

  • Helps to lower blood sugar levels and A1C
  • Is taken once daily with or without food
  • Is available by prescription only

How ZITUVIO (sitagliptin) Works

To understand how ZITUVIO works, it's important to know how your body uses food as energy.

After you eat a meal, a hormone called GLP-1 is released from the small intestine. GLP-1 has two main functions:

  • It signals the pancreas to release insulin.
  • It tells the brain that you’re full.

These actions help lower blood sugar levels and control appetite.

However, GLP-1 is short-lived and is quickly deactivated by an enzyme called DPP-4. For healthy people, this short period is enough for GLP-1 to do its job. But for those with Type 2 Diabetes, this can be problematic. DPP-4 inhibitors like ZITUVIO (sitagliptin) block DPP-4 from deactivating GLP-1, allowing it to remain active longer and continue its beneficial effects.

What’s unique about ZITUVIO is its ability to adapt its effects based on the body's needs. Its blood sugar-lowering effects are most pronounced when there is increased glucose in the blood, such as after a meal. These effects diminish between meals, reducing the risk of hypoglycemia (low blood sugar), which can be very dangerous. This makes ZITUVIO a safe and effective treatment option for managing Type 2 Diabetes.

ZITUVIO (sitagliptin) Clinical Data in Multiple Settings

Sitagliptin has been studied as an add-on medication for treatment of Type 2 Diabetes when A1C levels are not at target. The extensive amount of data about this medication allows healthcare providers with confidence regarding its effectiveness and safety. This includes its use:

  • Alone
  • With metformin (1000 mg and 2000 mg daily dose of metformin)
  • With pioglitazone
  • With rosiglitazone + metformin
  • With glimepiride (+/- metformin)
  • With insulin (+/- metformin)

In all situations the use of ZITUVIO resulted in additional decreases in fasting blood sugar, 2-hour post meal blood sugar, and A1C. This provides important evidence supporting this medication’s effectives and safety in various real-world situations.

Common Questions About ZITUVIO (sitagliptin)